Gavin Clark - Graduate Chemist (University of Strathclyde) with 30 years experience in the industry including commercial positions at Janssen Pharmaceutica, Bayer and Novartis.
More recently he
was responsible for Global Infectious Diseases Licensing at GlaxoWellcome
and VP Business Development at Tibotec Pharmaceuticals
In the former role he
closed 8 deals including those with Otsuka, Paratek, and Pliva and was responsible for business development at Tibotec
until the acquisition by Johnson & Johnson
Since then Clark
has consulted in commercial roles and has - since the first multimillion dollar and company transforming deal for Acumen Pharmaceuticals in 2003 -been consistently been behind a number of fundraising, M&A and Licensing deals for his
client base in USA, Asia Pacific and EU.
He is a Chief Business Officer and Founder at MGB Biopharma Limited and also serves on the Scottish Life Sciences Association Advisory board.